MoMa Therapeutics Stock
MoMa Therapeutics is a biotechnology company focused on discovering and developing precision medicines. They specialize in targeting molecular machines that are fundamental to human diseases, aiming to advance drug discovery processes and improve patient outcomes. Their approach is driven by a commitment to adapting drug discovery techniques to better address key disease targets.
Sign up for SecondMarket® to view the market and buy or sell MoMa Therapeutics Stock
Buy + SellSee MoMa Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into MoMa Therapeutics Stock Valuation + Share Prices
View real-time Tape D® data on MoMa Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get StartedMoMa Therapeutics Management Team
-
Chief People Officer
Adam Thomas
-
Co-Founder
Timur Yusufzai
-
Chief Scientific Officer
Peter Hammerman
-
Board Member
Amit Sinha
-
Board Member
Reid Huber
-
Board Member
Walt Kowtoniuk
-
Board Member
Thilo Schroeder
-
Board Member
Christoph Lengauer
-
Co-Founder
Johannes Walter
-
CEO, Board Member
Asit Parikh
-
Co-Founder
Dorethee Kern
-
Co-Founder
Eva Nogales
-
Board Member
Jeff Albers
Learn More About MoMa Therapeutics Stock
Buy MoMa Therapeutics Stock
01MoMa Therapeutics stock does not trade on public stock exchanges. MoMa Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in MoMa Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell MoMa Therapeutics Stock
02MoMa Therapeutics Stock does not trade on public stock exchanges. In order to sell MoMa Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
MoMa Therapeutics Stock Price
03MoMa Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view MoMa Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
MoMa Therapeutics Stock Ticker Symbol
04There is no ticker symbol for MoMa Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell MoMa Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell MoMa Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in MoMa Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in MoMa Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
MoMa Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
MoMa Therapeutics IPO
08MoMa Therapeutics is a private company and has not had an IPO. There is currently no MoMa Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to MoMa Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell MoMa Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.